THIRD OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement • August 1st, 2023 • ClearPoint Neuro, Inc. • Surgical & medical instruments & apparatus
This THIRD OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTES (this “Third Amendment”) is dated as of July 31, 2023 and is made in reference to that certain Securities Purchase Agreement, dated as of January 11, 2020 (as heretofore has been, and as hereafter may be, amended, restated or otherwise modified, the “Purchase Agreement”), by and among ClearPoint Neuro, Inc. (previously named MRI Interventions, Inc.), a Delaware corporation (the “Company”), the investors identified on the signature pages thereto (the “Investors”), Petrichor Opportunities Fund I LP, as resigning collateral agent (the “Resigning Agent”) and PTC Therapeutics, Inc. (“PTC”), as successor agent as set forth below (collectively, the “Parties”) and the Notes (as hereinafter defined) issued thereunder.
